Compare CTS & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTS | INNV |
|---|---|---|
| Founded | 1896 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 1994 | 2021 |
| Metric | CTS | INNV |
|---|---|---|
| Price | $47.85 | $7.90 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 182.2K | ★ 330.4K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.33% | N/A |
| EPS Growth | ★ 15.87 | N/A |
| EPS | ★ 2.19 | 0.14 |
| Revenue | $541,318,000.00 | ★ $853,699,000.00 |
| Revenue This Year | $5.55 | $12.85 |
| Revenue Next Year | $5.00 | $8.88 |
| P/E Ratio | ★ $22.22 | $56.50 |
| Revenue Growth | 4.95 | ★ 11.76 |
| 52 Week Low | $34.02 | $2.60 |
| 52 Week High | $59.66 | $10.69 |
| Indicator | CTS | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 44.00 | 44.64 |
| Support Level | $39.24 | $7.69 |
| Resistance Level | $59.66 | $9.18 |
| Average True Range (ATR) | 1.45 | 0.40 |
| MACD | 0.24 | -0.16 |
| Stochastic Oscillator | 42.25 | 11.03 |
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEMs) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China, Singapore, the Czech Republic, Taiwan, Denmark, and other countries.
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.